CN1953739B - 药物制剂 - Google Patents

药物制剂 Download PDF

Info

Publication number
CN1953739B
CN1953739B CN200580015367XA CN200580015367A CN1953739B CN 1953739 B CN1953739 B CN 1953739B CN 200580015367X A CN200580015367X A CN 200580015367XA CN 200580015367 A CN200580015367 A CN 200580015367A CN 1953739 B CN1953739 B CN 1953739B
Authority
CN
China
Prior art keywords
capsule
subunit
articulamentum
shell wall
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200580015367XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1953739A (zh
Inventor
阿德里安·布朗
丹尼尔·N·马吉特森
韦恩·M·马修斯
斯蒂芬·M·麦卡利斯特
小罗纳德·K·雷比
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsule Belgium LLC
Smiscle Buchman Ltd
Capsugel Belgium NV
Pfizer Inc
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1953739A publication Critical patent/CN1953739A/zh
Application granted granted Critical
Publication of CN1953739B publication Critical patent/CN1953739B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Injection Moulding Of Plastics Or The Like (AREA)
CN200580015367XA 2004-03-12 2005-03-11 药物制剂 Expired - Fee Related CN1953739B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55249904P 2004-03-12 2004-03-12
US60/552,499 2004-03-12
PCT/US2005/008147 WO2005089726A1 (en) 2004-03-12 2005-03-11 Pharmaceutical formulations

Publications (2)

Publication Number Publication Date
CN1953739A CN1953739A (zh) 2007-04-25
CN1953739B true CN1953739B (zh) 2011-12-14

Family

ID=34993424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580015367XA Expired - Fee Related CN1953739B (zh) 2004-03-12 2005-03-11 药物制剂

Country Status (17)

Country Link
US (3) US8147871B2 (enExample)
EP (1) EP1729744A4 (enExample)
JP (2) JP2007528901A (enExample)
KR (3) KR20120044365A (enExample)
CN (1) CN1953739B (enExample)
AR (1) AR048033A1 (enExample)
AU (1) AU2005222612C1 (enExample)
BR (1) BRPI0508342A (enExample)
CA (1) CA2559227A1 (enExample)
IL (1) IL177566A (enExample)
MA (1) MA28489B1 (enExample)
NO (1) NO20064570L (enExample)
NZ (1) NZ549264A (enExample)
PE (1) PE20060003A1 (enExample)
RU (2) RU2447885C2 (enExample)
TW (2) TW201240679A (enExample)
WO (1) WO2005089726A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
EP2359817B1 (en) * 2003-03-28 2018-01-10 Sigmoid Pharma Limited Solid oral dosage form containing seamless microcapsules
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
DE602005010899D1 (de) * 2004-09-27 2008-12-18 Sigmoid Pharma Ltd Mikrokapseln mit einem methylxanthin und einem kortikosteroid
EP1836665B1 (en) * 2004-11-19 2013-01-16 GlaxoSmithKline LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies
BRPI0520830A2 (pt) * 2005-12-30 2009-05-19 Accu Break Technologies Inc forma de dosagem farmacêutica sólida, método de subdividir uma forma de dosagem farmacêutica sólida, método de administração de uma parte de uma subunidade ativa de uma forma de dosagem farmacêutica sólida, método de administração de um ingrediente farmacêutico ativo que está presente dentro de uma subunidade ativa de uma forma de dosagem farmacêutica sólida e método de produção de uma forma de dosagem farmacêutica sólida
BRPI0707616A2 (pt) 2006-02-09 2011-05-10 Alba Therapuetics Corp formulaÇÕes para um efetor de junÇço oclusiva
CA2652620A1 (en) * 2006-06-02 2007-12-13 Teva Pharmaceutical Industries Ltd. Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
US8034776B2 (en) 2006-10-26 2011-10-11 Alba Therapeutics Corporation Materials and methods for the treatment of celiac disease
EP2380564B1 (en) * 2007-04-04 2014-10-22 Sigmoid Pharma Limited An oral pharmaceutical composition
JP2010527285A (ja) * 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
NZ580803A (en) * 2007-04-27 2012-03-30 Endo Pharmaceuticals Solutions Implant device release agents and methods of using same
CA2685591A1 (en) * 2007-05-01 2008-11-06 Sigmoid Pharma Limited Pharmaceutical nimodipine compositions
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2219583B1 (en) 2007-10-15 2012-11-21 Capsugel Belgium NV Method and apparatus for manufacturing filled linkers
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
EP2227226B1 (en) * 2007-12-21 2016-10-26 Johnson & Johnson Consumer Inc. Manufacture of a tablet
EP2320876A2 (en) * 2008-06-13 2011-05-18 Pfizer Inc. Hydroxypropyl cellulose capsule shell
IT1393245B1 (it) * 2008-07-24 2012-04-12 Universita' Degli Studi Di Milano Forme farmaceutiche per il rilascio tempo-specifico di farmaci
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
CN109044985A (zh) 2009-01-09 2018-12-21 前进制药知识产权有限公司 包含溶蚀骨架中的一种或多种富马酸酯的药物制剂
CN105213318A (zh) 2009-05-18 2016-01-06 希格默伊德药业有限公司 包含油滴的组合物
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
AU2011224350B2 (en) * 2010-03-09 2015-07-02 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
KR101900966B1 (ko) * 2010-10-26 2018-09-20 캡슈겔 벨지엄 엔브이 벌크한 장용성 캡슐 쉘
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
WO2013055668A1 (en) 2011-10-12 2013-04-18 Dow Global Technologies Llc Injection-molded dosage form
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
EP3065720A1 (en) 2013-11-04 2016-09-14 Capsugel Belgium NV Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
TWI535784B (zh) 2014-08-26 2016-06-01 財團法人工業技術研究院 剪切增稠配方、及包含其之複合材料
DK3215127T3 (da) 2014-11-07 2021-02-01 Sublimity Therapeutics Ltd Sammensætninger omfattende cyclosporin
US20160331689A1 (en) 2015-05-12 2016-11-17 SE Tylose USA, Inc. Aqueous enteric coating composition
CN118975972A (zh) * 2015-10-23 2024-11-19 林德拉治疗公司 用于治疗剂缓释的胃驻留系统及其使用方法
BR112018011636B1 (pt) 2015-12-08 2024-03-12 Lyndra Therapeutics, Inc Sistema de residência gástrico para liberação sustentada de um agente terapêutico
CN119925721A (zh) 2016-05-27 2025-05-06 林德拉治疗公司 用于胃驻留系统的材料结构
CN110022861B (zh) 2016-09-30 2024-06-28 林德拉治疗公司 用于金刚烷类药物缓释的胃驻留系统
AU2018279853B2 (en) 2017-06-09 2024-07-04 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
WO2019082171A1 (en) * 2017-10-27 2019-05-02 Alvit Pharma ORAL CANNABINOID COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY
CN112499717B (zh) * 2020-12-10 2021-10-22 江南大学 一种聚合物包含膜在染料吸附中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576284A (en) * 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US5672359A (en) * 1993-07-21 1997-09-30 The University Of Kentucky Research Foundation Multicompartment hard capsule with control release properties

Family Cites Families (163)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186910A (en) * 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
US3278521A (en) 1963-02-08 1966-10-11 Hercules Inc Hydroxypropyl cellulose and process
US3394983A (en) * 1963-06-14 1968-07-30 American Cyanamid Co Dip-dyeing capsules
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3399803A (en) 1966-10-11 1968-09-03 Parke Davis & Co Self-locking medicament capsule
US3779942A (en) 1970-12-04 1973-12-18 Minnesota Mining & Mfg Capsules and process for forming capsules
US3723312A (en) 1970-12-18 1973-03-27 Ppg Industries Inc Combined stain retardant and separator interleaving material for glass sheets
DE2428397C3 (de) 1974-06-12 1978-05-18 Scherer Hartkapsel Gmbh, 6930 Eberbach Zweiteilige Kapsel aus Hartgelatine
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
DE2722822C2 (de) 1977-05-20 1984-11-08 Capsugel AG, Basel Verfahren zum Herstellen einer zum Aufnehmen eines viskosen Stoffes, insbesondere eines flüssigen Arzneimittels, geeigneten Steckkapsel
US4250097A (en) * 1978-03-08 1981-02-10 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
FI63335B (fi) 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4281763A (en) 1979-10-31 1981-08-04 Pace Joseph A Two-piece hardshell, soluble and digestible liquid containing gelatin capsule
US4766728A (en) * 1983-03-28 1988-08-30 Rexa Corporation Flow matching valve and hydraulic system employing same
US4417591A (en) 1980-12-31 1983-11-29 Braintech, Inc. Apparatus and method for topographic display of multichannel EEG data
US4498080A (en) 1980-12-31 1985-02-05 Braintech, Inc. Apparatus and method for topographic display of multichannel data
USRE34390E (en) 1980-12-31 1993-09-28 Nicolet Instrument Corporation Apparatus and method for topographic display of multichannel EEG data
US4378817A (en) * 1981-07-06 1983-04-05 Superior Valve Corporation Slide valve assembly
WO1983001454A1 (en) 1981-10-21 1983-04-28 Smith, Charles, E. A method and composition for substrate coating
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4550238A (en) 1982-11-05 1985-10-29 Warner-Lambert Company Apparatus and method for sealing capsules
USD285837S (en) 1982-12-20 1986-09-23 Warner-Lambert Company Pharmaceutical capsule
US4487327A (en) 1982-12-21 1984-12-11 Grayson Robert E Locking capsule
US4625513A (en) 1983-03-28 1986-12-02 Rexa Corporation Controlled flow hydraulic system
US4557180A (en) 1983-03-28 1985-12-10 Rexa Corporation Control valve and hydraulic system employing same
US4696163A (en) 1983-03-28 1987-09-29 Rexa Corporation Control valve and hydraulic system employing same
US4543138A (en) 1983-07-07 1985-09-24 Eli Lilly & Company Capsule-sealing method and apparatus
US4564363A (en) 1983-07-13 1986-01-14 Smithkline Beckman Corporation Delayed action assembly
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738817A (en) * 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US4673438A (en) * 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
EP0164669B1 (de) 1984-06-13 1991-01-23 Röhm Gmbh Verfahren zum Überziehen von Arzneiformen
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
DE3438291A1 (de) 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
GB2172569A (en) 1985-03-21 1986-09-24 Warner Lambert Co Improved capsule construction
WO1986004501A1 (fr) 1985-01-31 1986-08-14 Fujisawa Pharmaceutical Co., Ltd. Capsule souple a cavites multiples; son procede et appareil de fabrication
DE3524963A1 (de) 1985-07-12 1987-01-22 Scherer R P Hartkapsel Gmbh Zweiteilige steckkapsel
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
DE3543912A1 (de) 1985-12-12 1987-06-19 Linde Ag Steuergeraet
EP0228067B1 (en) 1985-12-26 1991-09-18 Taisho Pharmaceutical Co. Ltd Seamless soft capsule
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4928840A (en) 1986-02-25 1990-05-29 American Home Products Corporation Tamper proof encapsulated medicaments
CH674800A5 (enExample) 1986-03-12 1990-07-31 Warner Lambert Co
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4936461A (en) * 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
DE3631826A1 (de) * 1986-09-19 1988-03-31 Roehm Gmbh Herstellung eines methylmethacrylat-copolymerisats
US5074426A (en) 1986-11-13 1991-12-24 Warner-Lambert Company Dividable capsule
KR890003520Y1 (ko) 1986-12-20 1989-05-27 주식회사 서흥캅셀 의약용 캅셀
US4724019A (en) * 1987-03-20 1988-02-09 Warner-Lambert Company Method and apparatus for sealing capsules
US5236689A (en) * 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US4795644A (en) 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
DE3735260A1 (de) 1987-10-17 1989-04-27 Bosch Gmbh Robert Verschliessvorrichtung fuer zweiteilige kapseln
DE3830013C2 (de) 1988-09-03 1996-10-17 Bosch Gmbh Robert Füll- und Schließmaschine für zweiteilige Kapseln
US4944906A (en) 1988-10-11 1990-07-31 Spirex Corporation Methods of injection molding and extruding wet hygroscopic ionomers
US5004601A (en) * 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5244668A (en) 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5135752A (en) * 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5139790A (en) * 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US4936074A (en) 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
DE3902653A1 (de) 1989-01-30 1990-08-02 Roehm Gmbh Elastomere acrylharze
US6200600B1 (en) 1989-02-16 2001-03-13 Btg International Limited Controlled delay release device
DE3907019A1 (de) * 1989-03-04 1990-09-06 Roehm Gmbh Thermoplastisch verarbeitbare loesungsmittelbestaendige kunststoffmischungen
JPH0729926B2 (ja) 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
US5456919A (en) 1989-12-29 1995-10-10 Bristol-Myers Squibb Company Capsule and caplet combination
DE4002904A1 (de) * 1990-02-01 1991-08-08 Roehm Gmbh Verfahren zum imidieren eines methacrylester-polymerisats
PT100054A (pt) 1991-01-30 1994-04-29 Alza Corp Dispositivo distribuidor que embebe um fluido, com duas pecas que se separam de maneira deslizante e processo para a descarga inicial retardada de um agente activo para um ambiente fluido
US5976571A (en) 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5674530A (en) 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5387421A (en) 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
DE4121652A1 (de) 1991-06-29 1993-01-07 Roehm Gmbh Schlagzaeh-modifizierungsmittel
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
GB9223144D0 (en) 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223172D0 (en) 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
US5312008A (en) 1993-05-26 1994-05-17 Davis Bradford L Personal time capsule
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4402666A1 (de) 1994-01-29 1995-08-03 Roehm Gmbh Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
JP3867171B2 (ja) * 1994-04-22 2007-01-10 アステラス製薬株式会社 結腸特異的薬物放出システム
DE19509807A1 (de) * 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
DE9414066U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE4445498A1 (de) * 1994-12-20 1996-06-27 Roehm Gmbh Universell verträgliche Pigmentdispergatoren
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE29502547U1 (de) 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
US5769267A (en) * 1995-11-09 1998-06-23 Warner-Lambert Company Container
DE19544562B4 (de) 1995-11-30 2004-05-27 Röhm GmbH & Co. KG Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper
DE19701441C2 (de) 1997-01-17 1998-11-05 Roehm Gmbh Verfahren zur Herstellung farbneutraler Polymethylmethacrylat-Formmassen
DE19718597C1 (de) 1997-05-02 1999-01-07 Roehm Gmbh Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
SK180499A3 (en) * 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DE19843904A1 (de) * 1998-09-24 2000-03-30 Basf Ag Feste Dosierungsform mit polymerem Bindemittel
US6139875A (en) 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
CA2352389C (en) * 1998-11-27 2009-01-20 Kanji Takada An oral formulation for gastrointestinal drug delivery
US6797283B1 (en) * 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
IT1316684B1 (it) 1999-03-13 2003-04-24 Bosch Gmbh Robert Supporto delle parti di capsule in una macchina di caricamento e dichiusura per capsule in due parti
US6248807B1 (en) 1999-03-15 2001-06-19 Fina Technology, Inc. Method for the preparation of core-shell morphologies from polybutadiene-polystyrene graft copolymers
DE19914605A1 (de) 1999-03-30 2000-10-05 Roehm Gmbh Polyalkylmethacrylat-Plastisole mit verbesserten Fließeigenschaften
CA2391707C (en) * 1999-07-30 2010-05-11 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
DE19958007A1 (de) * 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
DE19960494A1 (de) * 1999-12-15 2001-06-21 Knoll Ag Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
DE19961334A1 (de) 1999-12-17 2001-06-21 Roehm Gmbh Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
MXPA02008023A (es) * 2000-02-18 2005-06-30 Yeda Res & Dev Formulaciones de copolimero 1 para dosificacion oral, nasal y pulmonar.
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
US6270797B1 (en) * 2000-05-18 2001-08-07 Usv Limited Sustained release pharmaceutical composition containing glipizide and method for producing same
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10043868A1 (de) 2000-09-04 2002-04-04 Roehm Gmbh PMMA Formmassen mit verbesserter Schlagzähigkeit
DE10054051A1 (de) * 2000-10-31 2002-05-29 Roehm Gmbh PMMA-Formmasse mit verbesserter Kälteschlagzähigkeit
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US20050175687A1 (en) 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
EA005537B1 (ru) * 2001-07-10 2005-04-28 Тева Фармасьютикал Индастриес Лтд. Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата
US6949154B2 (en) * 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
USD481456S1 (en) 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
DE10204890A1 (de) 2002-02-06 2003-08-14 Roehm Gmbh Schlagzähe Formmasse und Formkörper
US20030194429A1 (en) 2002-04-10 2003-10-16 Miller Frederick H. Multi-phase, multi-compartment capsular delivery apparatus for therapeutic compositions and methods for using same
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
USD506545S1 (en) * 2002-07-29 2005-06-21 Smithkline Beecham P.L.C. Capsule linker
DE10243062A1 (de) 2002-09-16 2004-03-25 Röhm GmbH & Co. KG Heißwasserwechseltestbeständiges Sanitärmaterial aus PMMA-Formmasse oder schlagzäher PMMA-Formmasse
DE10260089A1 (de) 2002-12-19 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von wässrigen Dispersionen
DE10260065A1 (de) 2002-12-19 2004-07-01 Röhm GmbH & Co. KG Kern-Schale-Teilchen zur Schlagzähmodifizierung von Poly(meth)acrylat-Formmassen
DE10329938A1 (de) * 2003-07-02 2005-03-17 Röhm GmbH & Co. KG Kunststoffkörper mit mikrostrukturierter Oberfläche
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
DE10349142A1 (de) 2003-10-17 2005-05-12 Roehm Gmbh Polymermischung sowie deren Verwendung für Spritzgußteile
DE10349144A1 (de) * 2003-10-17 2005-05-12 Roehm Gmbh Polymermischung für mattierte Spritzgußteile
DE10351535A1 (de) * 2003-11-03 2005-06-09 Röhm GmbH & Co. KG Mehrschichtfolie aus (Meth)acrylatcopolymer und Polycarbonat
DE10354379A1 (de) * 2003-11-20 2005-06-23 Röhm GmbH & Co. KG Formmasse, enthaltend ein Mattierungsmittel
US20070160677A1 (en) 2004-01-16 2007-07-12 Pillai Raviraj S Encapsulation of lipid-based formulations in enteric polymers
DE102004022540A1 (de) 2004-05-05 2005-12-08 Röhm GmbH & Co. KG Formmasse für Formkörper mit hoher Witterungsbeständigkeit
JP4354360B2 (ja) * 2004-07-26 2009-10-28 Ｏｋｉセミコンダクタ株式会社 降圧電源装置
DE102004045296A1 (de) 2004-09-16 2006-03-23 Röhm GmbH & Co. KG Verwendung von Polyalkyl (meth) acrylat-Perlpolymerisaten und Formmasse zur Herstellung von extrudierten Formteilen mit mattierter Oberfläche
MX2007012220A (es) 2005-04-06 2007-12-06 Mallinckrodt Inc Formulacion farmaceutica de liberacion por pulsos a base de matriz.
EP2219583B1 (en) * 2007-10-15 2012-11-21 Capsugel Belgium NV Method and apparatus for manufacturing filled linkers
CN101827571A (zh) * 2007-10-15 2010-09-08 葛兰素集团有限公司 用于释放一种或多种药物成分的多部分剂型的连接件及所得剂型
EP2209455A1 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
JP2011500626A (ja) * 2007-10-15 2011-01-06 グラクソ グループ リミテッド １種または複数の物質を段階的に放出させるためのマルチパートカプセル
EP2219624A2 (en) * 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
EP2320876A2 (en) * 2008-06-13 2011-05-18 Pfizer Inc. Hydroxypropyl cellulose capsule shell

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576284A (en) * 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
US5672359A (en) * 1993-07-21 1997-09-30 The University Of Kentucky Research Foundation Multicompartment hard capsule with control release properties

Also Published As

Publication number Publication date
AU2005222612C1 (en) 2011-12-08
EP1729744A1 (en) 2006-12-13
EP1729744A4 (en) 2012-10-31
RU2011127852A (ru) 2013-01-20
AR048033A1 (es) 2006-03-22
RU2006136020A (ru) 2008-04-20
US20050249807A1 (en) 2005-11-10
WO2005089726A1 (en) 2005-09-29
TW200539903A (en) 2005-12-16
KR20120044365A (ko) 2012-05-07
AU2005222612A1 (en) 2005-09-29
KR20070002004A (ko) 2007-01-04
BRPI0508342A (pt) 2007-07-24
IL177566A (en) 2011-03-31
KR101242988B1 (ko) 2013-03-13
JP2012097088A (ja) 2012-05-24
US20070178156A1 (en) 2007-08-02
US20120196940A1 (en) 2012-08-02
TW201240679A (en) 2012-10-16
NZ549264A (en) 2010-07-30
IL177566A0 (en) 2006-12-10
KR20130010511A (ko) 2013-01-28
PE20060003A1 (es) 2006-03-01
RU2447885C2 (ru) 2012-04-20
CN1953739A (zh) 2007-04-25
JP2007528901A (ja) 2007-10-18
CA2559227A1 (en) 2005-09-29
US8147871B2 (en) 2012-04-03
AU2005222612B2 (en) 2011-04-21
MA28489B1 (fr) 2007-03-01
NO20064570L (no) 2006-10-10

Similar Documents

Publication Publication Date Title
CN1953739B (zh) 药物制剂
US8361498B2 (en) Pharmaceutical formulation
EP2366382A2 (en) Pharmaceutical formulation
US20110117190A1 (en) Pharmaceutical Formulations
AU2002242024A1 (en) Pharmaceutical formulation
CN102119026A (zh) 羟丙基纤维素胶囊壳
JP2012140433A (ja) 製薬用処方
US7883721B2 (en) Pharmaceutical formulation
US20050175687A1 (en) Pharmaceutical formulations
MXPA06010335A (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SMITHKLINE BEECHAM LIMITED

Free format text: FORMER OWNER: SMIHKLINE BEECHAM PLC

Effective date: 20120131

Owner name: BELGIUM CAPSULE CO., LTD.

Free format text: FORMER OWNER: PFIZER INC. (US) 235 EAST 42ND STREET, NEW YORK, N.Y.10017 U.S.A.

Effective date: 20120131

Owner name: PFIZER INC. (US) 235 EAST 42ND STREET, NEW YORK, N

Free format text: FORMER OWNER: SMITHKLINE BEECHAM LIMITED

Effective date: 20120131

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: BELGIUM CAPSULE CORPORATION

Free format text: FORMER NAME: BELGIUM CAPSULE CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: Bornem, Belgium

Patentee after: Capsugel Belgium N.V.

Address before: Bornem, Belgium

Patentee before: Capsule Belgium LLC

TR01 Transfer of patent right

Effective date of registration: 20120131

Address after: British Meader Sykes

Patentee after: Smiscle Buchman Ltd.

Address before: British Meader Sykes

Patentee before: SMITHKLINE BEECHAM PLC

Effective date of registration: 20120131

Address after: American New York

Patentee after: Pfizer Inc.

Address before: British Meader Sykes

Patentee before: Smiscle Buchman Ltd.

Effective date of registration: 20120131

Address after: Bornem, Belgium

Patentee after: Capsule Belgium LLC

Address before: American New York

Patentee before: Pfizer Inc.

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111214

Termination date: 20140311